MORIMATSU INTL (02155) has canceled 2.074 million repurchased shares.

date
10/01/2025
avatar
GMT Eight
MORIMATSU INTL (02155) announced that on January 10, 2025, the company has cancelled 2,074,000 repurchased shares.
pre
The China Securities Regulatory Commission (CSRC) has approved New Asia Electric Cable's application for an initial public offering (IPO) on the Shenzhen Stock Exchange main board.
Harbin Pharmaceutical Group (600664.SH): The dextrose benzene sulfonate benzoate tablets produced by Harbin Pharmaceutical Group Factory Six have been discontinued in 2018. The related reports have confused the trademark name with the drug name.
next

RECOMMEND

recommend

Song Xuetao: What incremental signals were released at the press conference of the five ministries?

date
19 min ago
recommend

Morgan Stanley: Key points for visiting the Chinese humanoid Siasun Robot & Automation industry

date
32 min ago
recommend

National Bureau of Statistics interpretation: The current moderate rebound in prices has not changed.

date
43 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com